CompletedNot Applicable

Fu's Subcutaneous Needling Treatment for Biceps Tendinopathy

Taiwan32 participantsStarted 2020-05-20

Plain-language summary

Biceps tendinopathy is a common cause in shoulder-pain symptoms. The major mechanism is overuse of the biceps muscles. The long-term accumulated and poor repaired trauma causes myofascial trigger points in the related muscles.We will conduct the randomized, open label experiment to evaluate the immediate, short-term, and long-term effect of Fu's subcutaneous needling (FSN).

Who can participate

Age range20 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Subjects older than 20 years of age who can cooperate with the experimental volunteers.
✓. Suffering from biceps tendon lesions for more than one month, and subjective pain intensity (VAS) greater than 5 points.
✓. There is a local tender point in front of the shoulder, and the shoulder joint pronation test can induce pain.
✓. Under soft tissue ultrasound, the thickness of biceps peritendinous effusion (BPE) on the affected side of the biceps tendon is greater than1 mm.

Exclusion criteria

✕. There are contraindications to general treatment, such as serious medical problems, recent serious trauma, or pregnant women.
✕. There has been a history of drug abuse (including excess alcohol) that affects pain assessors.
✕. Have received shoulder, neck or upper back surgery.
✕. People with central or peripheral nerve disease.
✕. Cognitive impairment, unable to cooperate with the experimenter.
✕. Patients currently receiving other treatments for biceps tendinopathy.
✕. Patients receiving shoulder injection treatments within the last 6 months.
✕. Patients with rheumatic diseases.

What they're measuring

Visual Analog Scales

Timeframe: before and after Day1, Day2, Day4 treatment ; on Day8 and Day15 separately

Trial details

NCT IDNCT04387591

SponsorChina Medical University Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2020-12-30

View on ClinicalTrials.gov More Bicep Tendinitis trials